Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BDKRB1 | P46663 | 20/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL492920 | 0.91 | BDKRB1 (0.47) | BDKRB1 | |
| SCHEMBL493243 | 0.88 | BDKRB1 (0.45) | BDKRB1 | |
| SCHEMBL13660734 | 0.82 | BDKRB1 (0.45) | BDKRB1 | |
| SCHEMBL4084739 | 0.80 | F2 (0.34) | — | |
| SCHEMBL4084745 | 0.79 | BDKRB1 (0.35) | BDKRB1 | |
| SCHEMBL493475 | 0.78 | TSHR (0.40) | BDKRB1 | |
| SCHEMBL3440038 | 0.77 | AVPR1B (0.45) | BDKRB1 | |
| SCHEMBL700853 | 0.76 | BDKRB1 (0.62) | BDKRB1 | |
| SCHEMBL2926610 | 0.76 | KDM4E (0.41) | BDKRB1 | |
| SCHEMBL15347791 | 0.75 | BDKRB1 (0.61) | BDKRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8263598-B2 | Substituted sulfonamide compounds | GRUENENTHAL GMBH (DE) | 2012-09-11 | — | — | US | disclosed |
| US-20090186899-A1 | Substituted Sulfonamide Compounds | GRUENENTHAL GMBH (DE) | 2009-07-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090186899-A1 | Substituted Sulfonamide Compounds | BDKRB1, BDKRB2, NPSR1 | BDKRB1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.